Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 2.1 Plan and Agreement of Merger
- 2.2 Certificate of Merger
- 3.1 Articles of Conversion
- 3.2 Certificate of Conversion
- 3.3 Amended and Restated Certificate of Incorporation
- 3.4 Amended and Restated Bylaws
- 3.5 Certificate of Correction
- 10.2 Series B Preferred Stock Purchase Agreemen
- 10.3 Series C Preferred Stock Purchase Agreement
- 10.4 Series D Preferred Stock Purchase Agreement
- 10.5 Series E Preferred Stock Purchase Agreement
- 10.6 Convertible Promissory Note
- 10.7 Services Agreement
- 10.8 Consulting Agreement
- 23.1 Consent
- 99.4 Consent
- 99.5 Consent
- EX-FILING FEES Filling Fee Table
- Download Excel data file
- View Excel data file
Associated filings
GLUC similar filings
Filing view
External links
EXHIBIT 99.4
CONSENT OF DIRECTOR NOMINEE
In connection with the filing by Glucose Health, Inc. (the “Company”) of a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents, as required by Rule 438 under the Securities Act, to being named in the Registration Statement as a Director Nominee.
May 18, 2022
By: | /s/ Robert Sipper |
|
|
Name: | Robert Sipper |
|
|